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Introduction
Stroke is the third leading cause of death in the developed countries and the leading cause of major adult disability. It was projected that, if the age-specific rates of stroke remain unchanged, the overall number of strokes in the United States will increase from approximately 700,000 in 2002 to 1136,000 in 2025, owing to the rising percentage of the population in older groups. Among the stroke patients, 85-90% of the cases are ischemic stroke with a predominant cause of cerebral arterial thrombosis. 1, 2 Brain injury following transient or permanent focal ischaemia (stroke) develops from a complex series of pathophysiological events that evolve over time and space. 3 These pathophysiological processes that contribute to neuronal death are discussed independently, 
. 4 The mechanisms underlying the ischaemic damage include; energy failure and loss of ion homeostasis, excitotoxicity, loss of calcium homeostasis, acidosis, cytokines and inflammation, alteration in systems regulating protein synthesis, local microvascular response to ischaemia-reperfusion (I/R), generation of free radicals, changes in genes expression and cell death either apoptotic or necrotic cell death. 5, 6 Ipsilateral and contralateral cortical apoptosis in rats after unilateral middle cerebral artery occlusion
Several studies, however, reported the occurrence of various functional alterations within the structurally intact brain regions, ipsilateral and contralateral to the focal ischaemia. These changes were termed as remote effects. Remote effects in turn, were divided into ipsilateral or contralateral effects; these contralateral effects were attributed to the extensive interhemispheric connections which existed in the rat cortex. Additionally, other mechanisms such as cerebral oedema, free radical formation or general stress response may contribute to the remote effects.
10,11
Animal stroke models have been used extensively in studying the pathophysiology of cerebral ischemia and in screening novel neuroprotective agents that may be applied to treat patients with strokes. 12 Desirable animal models are those that replicate features of human cerebrovascular syndromes. Rodent stroke models are divided into two types: focal and global cerebral ischemic models. The focal cerebral ischemic models are divided into permanent and transient models according to the stroke researcher's design. Of these methods for replicating ischemia, the use of MCAO is the most prevalent. Permanent MCAO can be produced using one of the following three techniques: direct ligation of the MCA by craniotomy, and intraluminal suturing without craniotomy, either via the ECA or via the CCA.
13,14

Materials and Methods
This study was performed on 40 male adult albino rats. Animals were housed individually at room temperature and standard condition with free access to standard laboratory diet, tap water ad libitum. All experimental procedures were conducted according to a protocol approved by the Governmental Animal Care Committee, Germany.
The animals were assigned to four experimental groups:
Group 1: Ten sham-operated rats were kept on standard diet serve as control.
Group 2: 10 rats were subjected to cerebral ischaemia for 30 minutes.
Group 3: 10 rats were subjected to cerebral ischaemia for 60 minutes.
Group 4: 10 rats were subjected to cerebral ischaemia for 90 minutes.
The animals in the experimental groups were subjected to transient middle cerebral artery occlusion. The animals were fasted overnight prior to surgery with free access to tap water. After complete anaesthesia, rats were placed on their back and a ventral midline cervical incision was made to isolate both sides of CCA. Both neck and cranial skin incision were closed. After surgery, animals were allowed to awake, and then they were transferred to their cages and reperfused for 7 days. The sections were then used for estimation of the following parameters: (All chemicals were obtained from Sigma Chemical Co., Germany unless otherwise stated).
Estimation of DNA fragmentation by terminal deoxynucleotidyl transferase mediated dUTP-biotin nick end labeling (TUNEL method)
Vibratome sections were processed and immunocytochemistry was performed with a mouse anti-BrdU monoclonal antibody (Progen-Heidelberg) and goat antimouse secondary antibody as described by Aschoff et al. with PBS) for 1 h at room temperature. Third antibody was then used which is goat peroxidase-antiperoxidase (in a dilution of 1:100 with PBS) for 1 h at room temperatureas described by Aschoff et al. 16 
Estimation of cytochrome c by immunoassay
In ELISA plate 20 μl of the homogenate was applied to each well. Sheep anticytochrome c antibody was added, (diluted with PBS triton, i.e. 0.1 M phosphate buffer PH 7.2 containing 0.5% tritonX-100 PBST 1:1000) to each well, and was incubated over night at 4 C°. The second antibody biotin labeled anti-sheep immunoglobulin was applied (diluted 1:100 with PBS triton) for 30 minutes at room temperature. Then third antibody streptavidin horseradish-peroxidase was added, (diluted 1: 100 with PBS triton) for 30 minutes.
The plate then was air-dried and evaluated using grey level reading software, flat Scan and a desktop scanner. Mean values of grey scale density were established from quadruplicate samples and standard curves were plotted (as previously described by Jirikowski, Groping et al., and Ekes et al. [17] [18] [19] ).
Results
Operative results
Group 1 (Sham operated animals): Showed no infarction.
Group 2: After 30 minutes of MCAO occlusion, 3 animals showed no macroscopic evidence of infarction and 7 animals showed cortical infarcts; 2 of them had both cortical and subcortical infarcts. After 60 minutes of left CCA occlusion all animals developed cortical infarction and 4 of them had both cortical and subcortical infarcts. The same findings were observed after 90 minutes of ischaemia. The infarct, however, developed in both cerebral hemispheres in 2 of the studied animals. 
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Discussion
Regarding the operative findings
In the present study, ipsilateral infarcts were reported in 28 of animals subjected to common carotid artery (CCA) and middle cerebral artery (MCA) occlusion for 30, 60 and 90 minutes and reperfused for 7 days. The most striking finding was the development of infarcts in the contralateral hemisphere in 2 of the studied animals.
Redecker et al. 11 reported the occurrence of various functional alterations within the structurally intact brain regions, ipsilateral and contralateral to the focal ischemia. These changes were termed as remote effects.
Remote effects in turn, were divided into ipsilateral or contralateral effects; these contralateral effects were attributed to the extensive interhemispheric connections which existed in the rat cortex. Additionally, other mechanisms such as cerebral oedema, free radical formation or general stress response may contribute to the remote effects. 10 On the other hand, these effects may be viewed as a form of (diaschisis), the term diaschisis was initially Death of neurons by ischaemia leads to lack in neurotrophic factors production and therefore, death of the neighboring cells (anterograde degeneration).
21
The effect of ischaemia on cytochrome c content of the brain
The mitochondria are the key intracellular site for sensing various death-inducing stimuli and transmitting them to the executional process of apoptosis. Release of stable intermembrane protein such as cytochrome c and apoptosis inducing factor from the mitochondria into the cytosol is a crucial step in the mitochondrial apoptotic signaling pathway. 22 The current study revealed the presence of cytochrome c in the sham operated animals (group 1), this could be due to that cytochrome c is naturally present in the space between the outer and inner membrane of mitochondria, where it functions in the respiratory chain. 23 In the present study, cytochrome c mean value was significantly higher in animals subjected to I/R (group 2) compared to sham operated group which prove its role in the apoptotic pathway. Cytochrome c in our study showed an early phase of increased production after 30 minutes ischaemia then gradually decreased with 60-90 minutes of ischaemia in animals subjected to I/R.
Several studies were in accordance with our finding and approved the role of cytochrome c as an early marker of apoptosis being detectable in the cytosol as early as 2 hours after reperfusion 24 or at 6-24 hours after ischaemia and was found in the region corresponding to the infarct zone. 25 Whereas, Ouyang et al. 26 demonstrated that cytochrome c release occurred as late as 36 hours after ischemia. Other investigators approved the presence of cytochrome c immunoreactivity in the ischaemic core which was prominent at 24 hour of reperfusion. sion suggests that cell damage in these neurons is a persisted and ongoing process. These findings were contradicted by Zeng et al. 33 who reported that, the morphological appearance of apoptosis is likely to be missing if the histochemical study is conducted 3-4 days after ischemia.
Therefore, the assumption that apoptosis occurs after an ischaemic insult raises the possibility that interventions directed against apoptosis would constitute a therapeutic strategy that may have attractive features;
1. Synergy with anti-excitotoxic intervention and 2. A prolonged therapeutic window. The ischaemic apoptosis occurs in delayed fashion after an ischaemic challenge, it is therefore possible that blockade of apoptosis may have a longer window of opportunity 1-2 h typically observed with calcium or glutamate antagonist drugs. As a matter of fact the protease inhibition offers a 6-h window of opportunity in focal cerebral ischaemia. 34, 35 
